Open AccessWhat Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?
Author(s) -
Christopher R. Flowers,
Scott D. Ramsey
Publication year - 2018
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2018.79.3570
Subject(s) - medicine , chimeric antigen receptor , lymphoblastic leukemia , antigen , leukemia , t cell receptor , immunology , oncology , cancer research , immunotherapy , t cell , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom